The imbalance between vasoconstriction and vasodilation through altered ACE2 expression is associated with hypertension and chronic pulmonary diseases such as idiopathic pulmonary fibrosis (IPF) (3–5). This evidence concerns the gene ACE2 and pulmonary fibrosis.